liraglutide (Saxenda) and semaglutide (Wegovy), which are GLP-1 receptor agonists with no clinically significant pharmacokinetic interactions with SSRIs according to their Summary of Product Characteristics (SmPC)
Mito Fuel includes the powerful antioxidant trio of alpha lipoic acid, N-acetyl cysteine and acetyl L-carnitine shown to increase energy production and at the same time, recharge the primary cellular antioxidant pools of vitamin E, C and glutathione
Schedule a consultation today to discuss your health and wellness needs and determine the best course of action for your well-being
As new oral GLP-1 options emerge, GoodRx is uniquely positioned to support patients as they navigate their treatment choices, said Wendy Barnes, president and CEO of GoodRx
Without that context, typical drug effects can look like red flags, leading to unnecessary worry, repeat testing, or even pressure to stop a treatment thats working